CERo Therapeutics Holdings, Inc.
CERO
$0.01
$0.00-9.91%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.63% | 6.50% | 10.35% | -6.10% | -859.92% |
| Total Depreciation and Amortization | 0.00% | 1.21% | 1.91% | -0.67% | -5.31% |
| Total Amortization of Deferred Charges | 29.79% | -78.92% | -- | -- | -- |
| Total Other Non-Cash Items | 860.53% | -25.35% | -60.94% | 93.10% | 112.35% |
| Change in Net Operating Assets | 133.76% | -82.47% | 245.77% | -417.05% | -105.68% |
| Cash from Operations | 27.46% | -18.76% | 30.67% | -3.99% | -188.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -68.57% | -- | -- | 7.51% | 277.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 5.25% | -- | -100.00% | -50.61% |
| Repurchase of Preferred Stock | -- | -- | -- | 100.00% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -301.26% | -- | -100.00% | 4,032.76% |
| Cash from Financing | -43.24% | 141.96% | -47.67% | -56.94% | 325.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.77% | 71.91% | 32.63% | -201.30% | 3,633.90% |